<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="nlm-table-wrap-2" xml:lang="en" orientation="portrait" position="anchor">
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" rowspan="2" valign="top" colspan="1">Treatments and outcomes</th>
    <th align="center" rowspan="2" valign="top" colspan="1">All patients</th>
    <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Therapy</th>
    <th align="center" rowspan="2" valign="top" colspan="1">
     <italic>P</italic>
    </th>
   </tr>
   <tr style="border-bottom:solid 1px #000000">
    <th align="center" valign="top" rowspan="1" colspan="1">Non‐corticosteroid</th>
    <th align="center" valign="top" rowspan="1" colspan="1">Corticosteroid</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Number of patients</td>
    <td align="char" rowspan="1" colspan="1">31</td>
    <td align="char" rowspan="1" colspan="1">20</td>
    <td align="char" rowspan="1" colspan="1">11</td>
    <td align="left" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Treatments</td>
    <td align="left" rowspan="1" colspan="1"/>
    <td align="left" rowspan="1" colspan="1"/>
    <td align="left" rowspan="1" colspan="1"/>
    <td align="left" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Antibiotics (all)</td>
    <td align="char" rowspan="1" colspan="1">15 (48%)</td>
    <td align="char" rowspan="1" colspan="1">7 (35%)</td>
    <td align="char" rowspan="1" colspan="1">8 (73%)</td>
    <td align="char" rowspan="1" colspan="1">0.10</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Moxifloxacin</td>
    <td align="char" rowspan="1" colspan="1">14 (45%)</td>
    <td align="char" rowspan="1" colspan="1">6 (30%)</td>
    <td align="char" rowspan="1" colspan="1">8 (73%)</td>
    <td align="char" rowspan="1" colspan="1">0.06</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Duration of moxifloxacin (days), median (IQR)</td>
    <td align="char" rowspan="1" colspan="1">6.5 (3.5–7.0)</td>
    <td align="char" rowspan="1" colspan="1">7 (5.5–7)</td>
    <td align="char" rowspan="1" colspan="1">7 (6–8.75)</td>
    <td align="char" rowspan="1" colspan="1">0.31</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Lopinavir/ritonavir and interferon alfa</td>
    <td align="char" rowspan="1" colspan="1">26 (84%)</td>
    <td align="char" rowspan="1" colspan="1">16 (80%)</td>
    <td align="char" rowspan="1" colspan="1">10 (91%)</td>
    <td align="char" rowspan="1" colspan="1">0.78</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Umifenovir and lopinavir/ritonavir and interferon alfa</td>
    <td align="char" rowspan="1" colspan="1">5 (16%)</td>
    <td align="char" rowspan="1" colspan="1">4 (20%)</td>
    <td align="char" rowspan="1" colspan="1">1 (9%)</td>
    <td align="char" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Duration of interferon alfa (days), median (IQR)</td>
    <td align="char" rowspan="1" colspan="1">15 (10–17)</td>
    <td align="char" rowspan="1" colspan="1">14.5 (10.5–17)</td>
    <td align="char" rowspan="1" colspan="1">16 (10.5–17.5)</td>
    <td align="char" rowspan="1" colspan="1">0.79</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Duration of antiviral drug (days), median (IQR)</td>
    <td align="char" rowspan="1" colspan="1">10 (8–11.5)</td>
    <td align="char" rowspan="1" colspan="1">10 (7.75–13)</td>
    <td align="char" rowspan="1" colspan="1">9 (8–10)</td>
    <td align="char" rowspan="1" colspan="1">0.48</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Outcomes</td>
    <td align="left" rowspan="1" colspan="1"/>
    <td align="left" rowspan="1" colspan="1"/>
    <td align="left" rowspan="1" colspan="1"/>
    <td align="left" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Recovered </td>
    <td align="char" rowspan="1" colspan="1">26 (84%)</td>
    <td align="char" rowspan="1" colspan="1">15 (75%)</td>
    <td align="char" rowspan="1" colspan="1">11 (100%)</td>
    <td align="char" rowspan="1" colspan="1">0.19</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Died</td>
    <td align="char" rowspan="1" colspan="1">0</td>
    <td align="char" rowspan="1" colspan="1">0</td>
    <td align="char" rowspan="1" colspan="1">0</td>
    <td align="char" rowspan="1" colspan="1">NA</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Virus clearance time (days), median (IQR)</td>
    <td align="char" rowspan="1" colspan="1">14 (11.5–16)</td>
    <td align="char" rowspan="1" colspan="1">14 (11–17)</td>
    <td align="char" rowspan="1" colspan="1">15 (14–16)</td>
    <td align="char" rowspan="1" colspan="1">0.87</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Duration of symptoms (days), median (IQR) </td>
    <td align="char" rowspan="1" colspan="1">7 (5–10.5)</td>
    <td align="char" rowspan="1" colspan="1">6.5 (4–9.25)</td>
    <td align="char" rowspan="1" colspan="1">8 (5–12)</td>
    <td align="char" rowspan="1" colspan="1">0.47</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Length of hospital stay (days), median (IQR)</td>
    <td align="char" rowspan="1" colspan="1">18.5 (16–21)</td>
    <td align="char" rowspan="1" colspan="1">17 (15.5–19.5)</td>
    <td align="char" rowspan="1" colspan="1">20 (18–21)</td>
    <td align="char" rowspan="1" colspan="1">0.14</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Kidney injury</td>
    <td align="char" rowspan="1" colspan="1">0</td>
    <td align="char" rowspan="1" colspan="1">0</td>
    <td align="char" rowspan="1" colspan="1">0</td>
    <td align="char" rowspan="1" colspan="1">—</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Liver injury</td>
    <td align="char" rowspan="1" colspan="1">12 (39%)</td>
    <td align="char" rowspan="1" colspan="1">7 (35%)</td>
    <td align="char" rowspan="1" colspan="1">5 (46%)</td>
    <td align="char" rowspan="1" colspan="1">0.85</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="mja250577-ntgp-0002">
  <fn id="mja250577-note-1002">
   <p>IQR = interquartile range; NA = not applicable.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
